Neurology is at a turning point. After decades of limited progress, new disease-modifying treatments (DMTs) for neurodegenerative conditions like Alzheimer’s and many others are finally reaching the ...

AUSTIN, Texas and TOKYO, Dec. 17, 2025 /PRNewswire/ -- According to DataM Intelligence, the global Disease-Modifying Therapies (DMTs) Market was valued at USD 65.32 billion in 2024 and is projected to ...

This video discusses the United States Navy’s DMTs, which stands for Dive Medical Technician. Navy DMT’s are Hospital Corpsman that have attended Navy Dive School and the Dive Medical Technician ...

The Minnesota Bureau of Criminal Apprehension says DWI breath tests administered with equipment that had data errors were accurate. "Since we first identified this issue, our BCA lab forensic ...

Please provide your email address to receive an email when new articles are posted on . The model predicted a 12.6% average risk for recurrent disease activity among DMT discontinuers. The model’s AUC ...

ROCHESTER — A machine used to measure the blood alcohol content of suspected impaired drivers in Olmsted County has been found to have an issue similar to what other counties have encountered, county ...

This video explores the role of the U.S. Navy’s Dive Medical Technicians (DMTs), a specialized path for Hospital Corpsmen who complete Navy Dive School and the Dive Medical Technician course. DMTs are ...

Many women with multiple sclerosis remained untreated before conception, during pregnancy, and postpartum, though preconception and postpartum ocrelizumab use increased between 2019 and 2023. Nearly ...

—Data from this real-world study revealed that patients with MS being treated with DMTs had a disproportionally higher number of cases of herpes zoster compared with patients treated with other ...

Proportion of treated women began to decline 18 months before childbirth, reaching 27.9% at the estimated time of conception. HealthDay News — Women with multiple sclerosis (MS) are less likely to ...

4D Molecular Therapeutics has posted 60-week data on a gene therapy, providing evidence of durability in diabetic macular edema (DME) and sending its stock up more than 40% in premarket trading. The ...

WEST PALM BEACH, Fla. — Discontinuing disease-modifying therapies (DMTs) for multiple sclerosis (MS) after prolonged disease stability poses minimal risk for patients aged > 60 years, highlighting the ...